Cargando…

Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium

Mostrar otras versiones (1)

BACKGROUND: Evidence on height and prostate cancer risk is mixed, however, recent studies with large data sets support a possible role for its association with the risk of aggressive prostate cancer. METHODS: We analysed data from the PRACTICAL consortium consisting of 6207 prostate cancer cases and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lophatananon, Artitaya, Stewart-Brown, Sarah, Kote-Jarai, Zsofia, Olama, Ali Amin Al, Garcia, Sara Benlloch, Neal, David E, Hamdy, Freddie C, Donovan, Jenny L, Giles, Graham G, Fitzgerald, Liesel M, Southey, Melissa C, Pharoah, Paul, Pashayan, Nora, Gronberg, Henrik, Wiklund, Fredrik, Aly, Markus, Stanford, Janet L, Brenner, Hermann, Dieffenbach, Aida K, Arndt, Volker, Park, Jong Y, Lin, Hui-Yi, Sellers, Thomas, Slavov, Chavdar, Kaneva, Radka, Mitev, Vanio, Batra, Jyotsna, Spurdle, Amanda, Clements, Judith A, Easton, Douglas, Eeles, Rosalind A, Muir, Kenneth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572182/ https://www.ncbi.nlm.nih.gov/pubmed/28765617 http://dx.doi.org/10.1038/bjc.2017.231

Ejemplares similares

Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium
por: Lophatananon, Artitaya, et al.
Publicado: (2018)

Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis
por: Pashayan, Nora, et al.
Publicado: (2015)

Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study
por: Callender, Tom, et al.
Publicado: (2019)

Association between Prostinogen (KLK15) Genetic Variants and Prostate Cancer Risk and Aggressiveness in Australia and a Meta-Analysis of GWAS Data
por: Batra, Jyotsna, et al.
Publicado: (2011)

Alcohol consumption and prostate cancer incidence and progression: A Mendelian randomisation study
por: Brunner, Clair, et al.
Publicado: (2016)

Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans
por: Amin Al Olama, Ali, et al.
Publicado: (2015)

Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort
por: Bonilla, Carolina, et al.
Publicado: (2016)

The effect of sample size on polygenic hazard models for prostate cancer
por: Karunamuni, Roshan A., et al.
Publicado: (2020)

Polyunsaturated fatty acids and prostate cancer risk: a Mendelian randomisation analysis from the PRACTICAL consortium
por: Khankari, Nikhil K, et al.
Publicado: (2016)

Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis
por: Taylor, Amy E., et al.
Publicado: (2016)

Identification of Germline Genetic Variants that Increase Prostate Cancer Risk and Influence Development of Aggressive Disease
por: Saunders, Edward J., et al.
Publicado: (2021)

Common genetic variants associated with disease from genome-wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis
por: Orozco, Gisela, et al.
Publicado: (2013)

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts
por: Seibert, Tyler M, et al.
Publicado: (2018)

The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium
por: Davies, Neil M., et al.
Publicado: (2015)

Relationship of self-reported body size and shape with risk for prostate cancer: A UK case-control study
por: Aladwani, Mohammad, et al.
Publicado: (2020)

CanRisk-Prostate: A Comprehensive, Externally Validated Risk Model for the Prediction of Future Prostate Cancer
por: Nyberg, Tommy, et al.
Publicado: (2023)

Novel mutation in Wilms’ tumour 1 gene associated with steroid-resistant nephrotic syndrome
por: Beltcheva, Olga, et al.
Publicado: (2011)

Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array
por: Saunders, Edward J, et al.
Publicado: (2018)

Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array
por: Saunders, Edward J, et al.
Publicado: (2016)

Assessing the role of insulin‐like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels
por: Bonilla, Carolina, et al.
Publicado: (2016)

LocusExplorer: a user-friendly tool for integrated visualization of human genetic association data and biological annotations
por: Dadaev, Tokhir, et al.
Publicado: (2016)

BRCA1, BRCA2 and their possible function in DNA damage response
por: Kote-Jarai, Z, et al.
Publicado: (1999)

IL-1RN VNTR Polymorphism in Adult Dermatomyositis and Systemic Lupus Erythematosus
por: Kamenarska, Zornitsa, et al.
Publicado: (2014)

Blood lipids and prostate cancer: a Mendelian randomization analysis
por: Bull, Caroline J., et al.
Publicado: (2016)

Role of the Promoter Polymorphism IL-6 −174G/C in Dermatomyositis and Systemic Lupus Erythematosus
por: Hristova, Maria, et al.
Publicado: (2013)

Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript
por: Kote-Jarai, Z., et al.
Publicado: (2011)

Germline genetic variation in prostate susceptibility does not predict outcomes in the chemoprevention trials PCPT and SELECT
por: Ahmed, Mahbubl, et al.
Publicado: (2019)

IDH1/IDH2 but Not TP53 Mutations Predict Prognosis in Bulgarian Glioblastoma Patients
por: Stancheva, Gergana, et al.
Publicado: (2014)

Prostate cancer risk in men of differing genetic ancestry and approaches to disease screening and management in these groups
por: McHugh, Jana, et al.
Publicado: (2021)

Validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancer
por: Loveday, Chey, et al.
Publicado: (2017)

Polygenic susceptibility to prostate and breast cancer: implications for personalised screening
por: Pashayan, N, et al.
Publicado: (2011)

CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers
por: Kadouri, L, et al.
Publicado: (2001)

Telomere Length Shows No Association with BRCA1 and BRCA2 Mutation Status
por: Killick, Emma, et al.
Publicado: (2014)

BRCA1, BRCA2 and pedigree genetic analysis to determine genetic risk in the UK Royal Marsden Hospital tamoxifen prevention trial
por: Kote-Jarai, Z, et al.
Publicado: (2000)

Author Correction: Large-scale transcriptome-wide association study identifies new prostate cancer risk regions
por: Mancuso, Nicholas, et al.
Publicado: (2019)

Large-scale transcriptome-wide association study identifies new prostate cancer risk regions
por: Mancuso, Nicholas, et al.
Publicado: (2018)

Mutation analysis of the MSMB gene in familial prostate cancer
por: Kote-Jarai, Z, et al.
Publicado: (2010)

A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer
por: Kote-Jarai, Z, et al.
Publicado: (2009)

Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype
por: Mitra, A, et al.
Publicado: (2008)

Gene promoter hypermethylation in ductal lavage fluid from healthy BRCA gene mutation carriers and mutation-negative controls
por: Locke, Imogen, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_bl25rvjifduakggj8k5e4oo2ag